Nabriva Therapeutics plc NBRV
1.42 +1.42
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 12.54M | 47.83M | 41.59M | 86.41M | 102.00M | |
| 12.54M | 47.83M | 41.59M | 86.41M | 102.00M | |
| 6.74M | 12.75M | 3.91M | 3.12M | 4.30M | |
| 31.10M | 80.27M | 57.22M | 91.17M | 108.75M | |
| 280.00K | 233.00K | 768.00K | 2.47M | 1.14M | |
| 31.77M | 80.91M | 58.44M | 94.11M | 110.42M | |
| 4.83M | 3.77M | 2.04M | 0 | 0 | |
| 5.22M | 8.03M | 7.73M | 34.50M | 23.72M | |
| 27.61M | 22.34M | 18.52M | 16.64M | 17.81M | |
| 388.00K | 4.26M | 5.69M | 34.50M | 23.72M | |
| 28.47M | 27.56M | 25.30M | 52.84M | 41.79M | |
| -652.86M | -595.68M | -546.23M | -476.74M | -393.98M | |
| 27.00K | 27.00K | 27.00K | 27.00K | 27.00K | |
| 3.29M | 53.35M | 33.13M | 41.27M | 68.63M | |
| 3.29M | 53.35M | 33.13M | 41.27M | 68.63M | |
| 661.00K | 644.00K | 1.22M | 2.94M | 1.67M | |
| 5.22M | 8.03M | 7.73M | 34.50M | 23.72M | |
| 3.00K | 31.00K | 80.00K | 91.00K | 98.00K | |
| 9.68M | 14.51M | 5.82M | 682.00K | 0 | |
| 867.00K | 5.22M | 6.78M | 36.20M | 23.98M | |
| 5.43M | 4.37M | 2.89M | 4.67M | 3.30M |